Volume 25, Number 3—March 2019
Synopsis
Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
Yu Pang1, Jun An1, Wei Shu1, Fengmin Huo, Naihui Chu, Mengqiu Gao, Shibing Qin, Hairong Huang, Xiaoyou Chen, and Shaofa Xu
Table 1
General characteristics of pulmonary TB and extrapulmonary TB patients, China, 2008–2017*
| Characteristic | No. (%) patients |
Crude OR (95% CI) | p value | Adjusted OR (95% CI) | p value | ||
|---|---|---|---|---|---|---|---|
| Pulmonary TB | Extrapulmonary TB | Total | |||||
| Sex | |||||||
| M | 8,757 (70.1) | 3,736 (29.9) | 12,493 | Referent | – | Referent | – |
| F |
4,089 (60.3) |
2,697 (39.7) |
6,786 |
1.55 (1.45–1.65) |
<0.01 |
1.37 (1.27–1.47) |
<0.001 |
| Age group, y | |||||||
| <25 | 2,024 (56.4) | 1,563 (43.6) | 3,587 | 2.51 (2.28–2.77) | <0.01 | 1.72 (1.53–1.93) | <0.001 |
| 25–44 | 3,539 (62.7) | 2,102 (37.3) | 5,641 | 1.93 (1.77–2.11) | <0.01 | 1.55 (1.40–1.73) | <0.001 |
| 45–64 | 4,078 (69.6) | 1,782 (30.4) | 5,860 | 1.42 (1.30–1.56) | <0.01 | 1.30 (1.17–1.44) | <0.001 |
| ≥65 |
3,205 (76.5) |
9,86 (23.5) |
4,191 |
Referent |
– |
Referent |
– |
| Residence | |||||||
| Urban | 9,789 (68.3) | 4,537 (31.7) | 1,4326 | Referent | – | Referent | – |
| Rural |
3,057 (61.7) |
1,896 (38.3) |
4,953 |
1.34 (1.25–1.43) |
<0.01 |
1.32 (1.22–1.43) |
<0.001 |
| Treatment history | |||||||
| New case | 10,967 (64.2) | 6,118 (35.8) | 17,085 | Referent | – | Referent | – |
| Retreated case |
1,879 (85.6) |
315 (14.4) |
2,194 |
0.30 (0.27–0.34) |
<0.01 |
0.24 (0.20–0.27) |
<0.001 |
| Diabetes | |||||||
| No | 12,502 (66.3) | 6,352 (33.7) | 18,854 | Referent | – | Referent | – |
| Yes |
344 (80.9) |
81 (19.1) |
425 |
0.46 (0.36–0.59) |
<0.01 |
0.54 (0.41–0.70) |
<0.001 |
| Culture determination | |||||||
| Negative | 6,256 (54.8) | 5,152 (45.2) | 11,408 | Referent | – | Referent | – |
| Positive |
6,080 (88.9) |
758 (11.1) |
6,838 |
0.15 (0.14–0.17) |
<0.01 |
0.16 (0.15–0.18) |
<0.001 |
| Smear determination | |||||||
| Negative | 8,343 (60.0) | 5,570 (40.0) | 13,913 | Referent | – | ||
| Positive |
4,000 (95.8) |
174 (4.2) |
4,174 |
0.07 (0.06–0.08) |
<0.01 |
||
| DST | |||||||
| MDR | 684 (89.2) | 83 (10.8) | 767 | 1.25 (0.97–1.61) | 0.084 | ||
| XDR | 322 (89.2) | 39 (10.8) | 361 | 1.25 (0.88–1.77) | 0.216 | ||
| Other | 3,716 (91.1) | 361 (8.9) | 4,077 | Referent | – | ||
*DST, drug susceptibility testing; MDR, multidrug-resistant; OR, odds ratio; TB, tuberculosis; XDR, extensively drug-resistant.
1These authors contributed equally to this article.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.